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H NMR (measured composition was PCL51, PTMC54) , comparing the protons of PEG (3.65-3.7 ppm), terminal methyl unit (singlet at 3.40 ppm) to PCL CH2 (multiplet at 2.40-2.25 ppm) and PTMC CH2 (multiplet at 2.2-1.8 ppm). GPC analysis (using a PL gel 5 µm mixed D column, with THF and PS standards) yielded a Đ of 1.1.
Step 2 -Chain-end modification with Boc-L-phenylalanine and deprotection. For the incorporation of a terminal amine onto the diblock copolymer, we performed a carbodiimide-mediated esterification between PEG-PClgTMC and Boc-L-phenylalanine (Boc-L-Phe). 1.3 g (ca. 0.1 mmol) of PEG-PClgTMC copolymer was dissolved in acetonitrile and to it was added dicyclohexylcarbodiimide (0.2 mmol, 41.9 mg), Boc-L-Phe (0.5 mmol, 23.4 mg), and 4-dimethylaminopyridine (0.02 mmol, 2.5 mg) on ice. The reaction mixture was stirred for 24 hrs at RT and afterwards placed directly in the freezer overnight to facilitate precipitation of dicyclohexylurea by-product. After cold filtration of the reaction mixture it was concentrated and then precipitated into cold methanol. 1 H NMR was used to check the product to confirm removal of the terminal TMC signal at 1.92 ppm and emergence of Boc protons at 1.45 ppm before deprotection. The resulting copolymer was then dissolved in 5 mL DCM, to which 5 mL of trifluoro acetic acid (TFA) was added (on ice) and the mixture was allowed to warm to RT and stirred for 2 hr. After 2 hr the solvent was evaporated and the copolymer was washed with NaHCO3, 1 M NaCl and brine before drying on MgSO4, filtration and evaporation of the majority of the solvent so that the copolymer could be precipitated from ice cold methanol. 1 H NMR clearly showed that the signal arising from the terminal TMC group had disappeared, due to addition of phenylalanine at the terminus, and aromatic protons were visible at around 7.2-7.3 ppm. GPC analysis before and after deprotection yielded a Đ of 1.1, indicating that TFA treatment did not facilitate copolymer hydrolysis.
Step 3 -Polymerization and deprotection of N-carboxyanhydride γ-benzyl L-glutamate (NCA-BLG). Following a published method for the controlled polymerization of NCA-BLG by lowering the temperature and maintaining a constant flow of N2 in order to remove CO2 by-product, [3] we aimed to add between 8 and 10 PBLG units onto the amine-terminus of the copolymer chains. 1 g of Pheterminated copolymer was weighed into a Schlenk flask and dissolved with ca. 3 mL of dry DMF and cooled in an ice bath. To the cooled mixture 160 mg of NCA-BLG was added under Ar and the reaction was left under a constant flow of N2 for 24 hrs. The product was precipitated into cold methanol and analysed by 1 H NMR to confirm the overall composition and, in particular, the presence of benzylic and aromatic protons at 5.0-5.2 and 7.1-7.4 ppm, respectively. Benzyl-protected terpolymer was dissolved in 10 mL THF and 10 mL of methanol was added before applying the H-Cube at 60 °C with 30 bar of H2 pressure and a flow rate of 1 mL/min to facilitate removal of benzyl protecting groups. The product was concentrated then precipitated into cold ether, dissolved in dioxane before lyophilisation to yield a waxy solid, 0.9 g (85 % yield). 1 H NMR was used to confirm successful deprotection of the PBLG units and GPC data indicated that the polydispersity didn't increase beyond 1.1 during this process.
Scheme 1:
Synthesis of PEG-b-PCLgPTMC-b-PGA terpolymer. Poly(ethylene glycol) monomethyl ether was used to initiate the ring opening polymerisation of ε-caprolactone and trimethylene carbonate (step 1). The terminal alcohol of this polymer was subsequently modified via a Steglich esterification with Boc-L-Phe-OH to yield a primary amine after TFA deprotection (step 2). The final poly(L-glutamic acid) block was introduced by the ring opening polymerisation of N-carboxyanhydride γ-benzyl Lglutamate, followed by hydrogenation (step 3).
Modified amylose (Q-Am and CM-Am)
Both quaternized (Q-Am) and carboxymethylated (CM-Am) were prepared in accordance with previously published procedures. [1] Q-Am was prepared by dissolving 1.5g of amylose and 2.78g of NaOH in 14.25 mL of Milli-Q at 35 °C. After complete dissolution of the amylose, 11.64 mL of 3-chloro-2-hydroxypropyltrimethylammonium chloride solution (60 wt% in water) was added dropwise into the stirring reaction mixture, which was subsequently left to react overnight. After this time, the mixture was neutralized with acetic acid and precipitated into 200 mL of cold ethanol. The resulting precipitate was re-dissolved in Milli-Q water and dialysed extensively against water using regenerated cellulose dialysis tubing (Spectrum Labs, USA) with a 3.5 kDa MWCO before lyophilization. Around 5 g of Q-Am was obtained from this reaction (ca. 80 % yield). 1 H NMR characterization data are presented in Figure S1a .
CM-Am was prepared by dissolving 1.5g of amylose and 3.6 g of NaOH in 15 mL of Milli-Q at 70 °C. After complete dissolution of the amylose, 2.7 g of chloroacetic acid was added and the reaction mixture was left to stir for 2 hours. After the reaction, the mixture was neutralized with acetic acid and precipitated into 200 mL of cold ethanol. The resulting precipitate was re-dissolved in Milli-Q water and dialysed extensively against water using regenerated cellulose dialysis tubing (Spectrum Labs, USA) with a 3.5 kDa MWCO before lyophilization. Around 3 g of CM-Am was obtained from this reaction (ca. 90 % yield). 
DNA Molecular Biology.
All DNA was ordered through Integrated DNA Technologies (IDT). The constructs were optimized using the IDT Codon Optimization Tool for Escherichia coli (E. coli) with the amino acid sequence as input and ordered as gBlock Gene Fragments (IDT). The vector pET-28a and the gBlocks were both digested using the restriction enzymes, NcoI and XhoI (New England Biolabs). The digested vector was purified using the QIAquick Gel Extraction Kit (Qiagen). The gBlocks were purified by QIAquick PCR Purification Kit (Qiagen). Both purified components were ligated, 1:3 ratio of vector to insert, using T4 Ligase (New England Biolabs). XL-1 Blue bacterial cells (Agilent Technologies) were transformed with the ligation product for amplification and extracted using the QIAprep Spin Miniprep Kit (Qiagen). The constructs were verified using Sanger sequencing (BaseClear).
Protein Expression and Purification
The expression and purification protocol was based on previous reports.
[4] Constructs were transformed into BL21(DE3) bacterial cells (Novagen). Expressions were carried out using lysogeny broth (LB) supplemented with kanamycin (100 µg ml -1 ). 600 mL 2YT media was inoculated using an overnight culture grown at cell pellets were resuspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0; for the GFP(+36) variant, 1 M NaCl was used) and lysed using an EmulsiFlexC3 High-Pressure homogenizer (Avestin) at 15000 psi for three rounds. For GFP(+36), 10 mg mL -1 DNaseI (PanReac AppliChem) and 5 mg mL -1 RNase A (ThermoFisher) were added 30 min before lysis. Cell debris and insoluble proteins were removed by centrifugation (15.000 xg, 10 min, 4 o C). The His-tagged proteins were purified from the soluble lysate using Ni-NTA affinity chromatography (His-Bind Resin, Novagen). The lysates were incubated with the His-bind resin for 1.5 h at 4 o C on a shaking table, prior to loading onto an empty gravity flow column (Bio-Rad). The resin was washed twice with wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0; again for the GFP(+36) variant, 1 M NaCl was used). The His-tagged proteins were eluted from the resin using elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0, for the GFP(+36) variant, 1 M NaCl was used). Extensive dialysis was performed using a 10 kDa molecular weight cut off (MWCO) membrane (Millipore), into PBS, pH 7.4 (for the superfolder GFP(-8) and GFP(-30) variants) or 50 mM NaPi, 600 mM NaCl, pH: 7.5 (for the GFP(+36) construct. Within the first 2 h, the solvent was replaced twice. The samples were concentrated using 3 kDa MWCO Amicon Ultra Filters (Millipore) and were further purified by sizeexclusion chromatography. The samples were passed through a HiLoad Superdex 200 pg preparative column (GE Healthcare) connected to an ÄKTApurifier FPLC (GE Healthcare) at a flow rate of 1 mL min -1 , and the absorbance at 280 and 488nm were both monitored. The eluted fractions were analyzed using SDS-PAGE (4-20% Mini-PROTEAN TGX Precast Protein Gel, Bio-Rad) and the most pure fractions were pooled and concentrated. Protein concentrations were calculated using the 280 nm absorbance determined by the ND-1000 spectrophotometer (Thermo Scientific) and theoretical extinction coefficients of 20400 M -1 cm -1 used as determined by the online ProtParam tool (ExPASy). The samples were aliquoted for single use, flash frozen in liquid N2 and stored at -80 o C. The purity of the samples were ascertained by using both SDS-PAGE as well as liquid chromatography quadrupole time of flight mass spectrometry (LC-MS Q-TOF) (Figure S3 and S4) .
LC-MS Q-TOF
The exact molecular weight of the purified GFP variants were determined using a high resolution LC-MS system consisting of an ACQUITY UPLC I-Class system coupled to a Xevo G2 QTOF (Waters). The protein was separated (0.3 mL min -1 ) on a Polaris C18A reverse phase column 2.0 x 100 mm (Agilent) using a 15 % to 75 % acetonitrile gradient in water supplemented with 0.1 % v/v formic acid before analysis in positive mode in the mass spectrometer. Deconvolution of the m/z spectra was done using the MaxENTI algorithm in the Masslynx v4.1 (SCN862) software.
Succinylated HRP uptake into the coacervate phase
HRP proteins, succinylated and non-succinylated, (5 µL of 5.6 µM solutions) were either mixed with 45 µL of PBS, or 30 µL Q-amylose (1 mg/mL) and 15 µL Cm-amylose (1 mg/mL) for the coacervate containing sample. Both samples with (+, Figure S9 ) and without coacervates (-, Figure S9 ) were hard spun at 21000 xg for 10 mins, and the top 7 µL ("polymer poor phase'') was gently pipetted off and mixed with 2X gel loading dye. Samples were boiled at 100 °C for 10 min and loaded, with a Precision Plus Protein™ molecular weight ladder (BioRad), onto a 10 well 4-20% Mini-PROTEAN® TGX™ Precast Protein Gel (BioRad). The gel was run according to manufacturer's instructions. Proteins were stained with Bio-Safe™ Coomassie G-250 stain according to manufacturer's protocol.
Table S1
Coacervate formation
Formation of coacervates at varying Q-Am:CM-Am ratios, using DSQ = DSCM = 0.8 
Figure S6
Effect of PGA group on terpolymer assembly Figure S6 . The poly(glutamic acid) moiety of the terpolymer is essential for interfacial self-assembly and stabilisation of coacervate droplets. These microscopy images show that when the diblock copolymer PEG-b-PCLgPTMC is used instead of the terpolymer, no evidence of membrane organisation around the droplets is observed, and no stabilisation occurs. Cy5 emission is from encapsulated Cy5-labelled, succinylated BSA. Scale bar represents 20 µm.
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Figure S7
Line profile analysis of confocal image for thickness measurement 
